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Introduction
Monoclonal antibodies (mAbs) are currently the highest-
selling products of the biopharmaceutical industry, having
had global sales of over $45 billion in 2012 [1]. All com-
mercially-available mAbs contain a consensus N-linked
glycosylation site on each of the Cg2 domains of their con-
stant fragment (Fc). The monosaccharide composition and
distribution of these N-linked carbohydrates (glycans) has
been widely reported to directly impact the safety and effi-
cacy of mAbs when administered to patients. Many studies
have also shown that manufacturing bioprocess conditions
(e.g. nutrient availability, metabolite accumulation, dis-
solved oxygen, pH, temperature and stirring speed) directly
influence the composition and distribution of N-linked gly-
cans bound to mAbs and other recombinant proteins.
Given this tight interconnection between manufacturing
process conditions, product quality and ensuing safety and
therapeutic efficacy, mAbs and their glycosylation present
a clear opportunity where process development can be
guided by quality by design (QbD) principles.
QbD is a conceptual framework that aims to build
quality into drug products at every stage of process devel-
opment. Specifically, implementation of QbD to pharma-
ceutical process development requires identifying critical
quality attributes (CQAs) that define the drug’s safety
and therapeutic efficacy. QbD then uses all available
information on the mechanisms that quantitatively relate
process inputs with product quality to control the manu-
facturing process so that product CQAs are maintained
and end-product quality is ensured. Within the QbD
context, composition and distribution of the glycans pre-
sent on the Fc of mAbs is defined as a CQA, and thus,
the processes employed in their manufacture must be
controlled so that their glycan distribution ensures the
required safety and efficacy profiles. Under this pers-
pective, we have defined a mathematical model that
mechanistically and quantitatively describes mAb Fc
glycosylation as a function of nutrient availability during
cell culture. Such a model aims to be used for bioprocess
design, control and optimisation, thus facilitating the
manufacture of mAbs with built-in glycosylation-associated
quality under the QbD scope.
Materials and methods
The mathematical model consists of three distinct modu-
lar elements which have been connected to achieve a
mechanistic description of mAb glycosylation as a func-
tion of nutrient availability. The first element corresponds
to cell culture dynamics and uses modified Monod
kinetics to describe the growth and death of cells as a
function of glucose and glutamine availability. This ele-
ment also describes accumulation of metabolites (lactate
and ammonia) and mAb synthesis throughout cell culture.
The second element describes the intracellular dynamics
of nucleotide sugar (NS) metabolism. NSs are the sub-
strates required for protein glycosylation and are synthe-
sised via the amino sugar and nucleotide sugar metabolic
pathway using glucose and glutamine as primary sub-
strates [2]. The full metabolic pathway has been heuristi-
cally reduced to 8 reactions by collapsing sequential
reactions along each distinct branch of the pathway into a
single one, as shown with the coloured arrows in Figure 1.
This module is linked with the cell culture dynamics
one by equations that define intracellular glucose and
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glutamine accumulation as a function of their availability
in the extracellular environment.
The pathway shows the synthesis of uridine diphosphate
N-acetylglucosamine (UDP-GlcNAc), uridine diphosphate
N-acetylgalactosamine (UDP-GalNAc), uridine dipho-
sphate glucose (UDP-Glc), uridine diphosphate galactose
(UDP-Gal), guanosine diphosphate mannose (GDP-Man),
guanosine diphosphate fucose (GDP-Fuc), cytosine mono-
phosphate N-acetylneuraminic acid (CMP-Neu5Ac) and
uridine diphosphate glucoronic acid (UDP-GlcA) using
glucose (Glc) and glutamine as substrates. The coloured
arrows represent the reduced scheme where sequential
reactions have been collapsed into a single one (e.g. the
blue arrow describes a single reaction that produces UDP-
GlcNAc using glucose and glutamine as substrates). The
remaining arrows represent the synthesis of the other NSs
using glucose and glutamine or other NSs as substrates.
The third element describes mAb Fc glycosylation as a
function of mAb specific productivity and NS availability.
This element approximates the Golgi apparatus to a plug-
flow reactor and considers the transport of NSs from the
cytosol, where they are synthesised, into the Golgi, where
they are consumed in glycosylation reactions [3]. As
inputs, this element requires intracellular NS availability
and mAb specific productivity, and is thus coupled to the
other two modules. All model simulation was performed
with gPROMS v. 3.4.0 [4].
Experimentally, murine hybridoma cells (CRL-1606,
ATCC) were cultured and typical data was collected
(viable cell density, extracellular glucose, glutamine, lac-
tate, ammonia and mAb titre). In addition, the intracellu-
lar pools of NSs were extracted using perchloric acid and
quantified using a high performance anion exchange
chromatographic method that allows for quantification of
8 NSs and 8 nucleotides in under 30 minutes [5]. Finally,
the mAb glycan profiles were obtained using MALDI
mass spectrometry.
The obtained experimental data was then used to esti-
mate the unknown parameters of the model. Estimation
was performed with the maximum likelihood formulation
available in gPROMS v. 3.4.0, where the values for uncer-
tain physical parameters are obtained to maximise the
probability that the model will predict values from experi-
mental measurements [4].
Figure 1 Nucleotide sugar metabolic network.
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Results
Time-courses for all data were produced, including intra-
cellular profiles for six NSs (GDP-Man, GDP-Fuc, UDP-
Glc, UDP-Gal, UDP-GlcNAc and CMP-Neu5Ac). This,
along with data on cell culture dynamics and mAb Fc gly-
cosylation were used to estimate the unknown parameters
of the model as described previously. With the estimated
parameters, the mathematical model was found to repro-
duce cell culture dynamics, intracellular NS pools and
terminal mAb Fc glycan distributions accurately.
With the obtained parameters, a case study for gluta-
mine depletion was simulated. This study showed that
under glutamine deprivation, intracellular availability of
UDP-GlcNAc decreases to a point where mAbs with high-
mannose (Man5) glycan structures begin accumulating in
the extracellular environment, a phenomenon that is con-
sistent with previous observations [6].
Conclusions
We have shown the construction of a mathematical
model which mechanistically and quantitatively describes
mAb Fc glycosylation as a function of nutrient availability
during cell culture. In addition, experimental methods
have been developed to generate data which was used to
estimate the unknown parameters of the model. Finally,
the model and obtained parameters were found to be
capable of reproducing previously observed effects of glu-
tamine depletion on protein glycosylation. With further
validation, this quantitative and mechanistic model could
prove useful in aiding process development, control and
optimisation for the manufacture of mAbs with desired
glycosylation-associated quality.
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